New Amsterdam Sciences' Unattributed Round

New Amsterdam Sciences raised a round of funding on November 19, 2015.

New Amsterdam Sciences (NAS) is a development-stage bioscience company focused on the research, development and licensing of analogues of Substance P. NAS911B, the company's lead compound, is being pu…

Articles about New Amsterdam Sciences' Unattributed Round: